Literature DB >> 3325255

Single doses of ofloxacin in uncomplicated gonorrhoea.

J Aznar1, R Prados, A Herrera, A Rodriguez-Pichardo, E J Perea.   

Abstract

The clinical efficacies of 2 different single-dose oral treatments of ofloxacin were evaluated in a double-blind, randomised study of 60 males with gonococcal urethritis. 30 patients received a single dose of ofloxacin 100mg and 30 received a single dose of ofloxacin 200mg. The minimal inhibitory concentrations of ofloxacin against all isolates were less than or equal to 0.25 mg/L. Neisseria gonorrhoeae was eradicated from all 50 patients evaluated and clinical cure was achieved in 84%. In total, 8 patients developed post-gonococcal urethritis, although there was a significantly (p less than 0.05) lower rate of post-gonococcal urethritis in the group treated with ofloxacin 200mg. In conclusion, a single oral dose of ofloxacin 100mg could be an alternative treatment for uncomplicated gonorrhoea.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3325255     DOI: 10.2165/00003495-198700341-00023

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  3 in total

1.  Analysis of Neisseria gonorrhoeae for in situ beta-lactamase production by reagent-impregnated filter paper replica methods.

Authors:  B H Bae; G Ledesma; J Korzis
Journal:  J Clin Microbiol       Date:  1983-03       Impact factor: 5.948

2.  Differential agar medium (A7) for identification of Ureaplasma urealyticum (human T mycoplasmas) in primary cultures of clinical material.

Authors:  M C Shepard; C D Lunceford
Journal:  J Clin Microbiol       Date:  1976-06       Impact factor: 5.948

3.  Activities of new quinoline derivatives against genital pathogens.

Authors:  J Aznar; M C Caballero; M C Lozano; C de Miguel; J C Palomares; E J Perea
Journal:  Antimicrob Agents Chemother       Date:  1985-01       Impact factor: 5.191

  3 in total
  5 in total

1.  Comparison of ofloxacin and ceftriaxone in the treatment of uncomplicated gonorrhea caused by penicillinase-producing and non-penicillinase-producing strains.

Authors:  J M Covino; M Cummings; B Smith; S Benes; K Draft; W M McCormack
Journal:  Antimicrob Agents Chemother       Date:  1990-01       Impact factor: 5.191

Review 2.  Ofloxacin. A reappraisal of its antimicrobial activity, pharmacology and therapeutic use.

Authors:  P A Todd; D Faulds
Journal:  Drugs       Date:  1991-11       Impact factor: 9.546

Review 3.  Quinolone antibacterial agents for the treatment of genitourinary tract infections.

Authors:  T J Babinchak; R J Fass
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-12       Impact factor: 3.267

Review 4.  Fluoroquinolone antibiotics. Microbiology, pharmacokinetics and clinical use.

Authors:  J H Paton; D S Reeves
Journal:  Drugs       Date:  1988-08       Impact factor: 9.546

5.  Effectiveness of norfloxacin and ofloxacin for treatment of gonorrhoea and decrease of in vitro susceptibility to quinolones over time in Rwanda.

Authors:  J Bogaerts; W M Tello; J Akingeneye; V Mukantabana; E Van Dyck; P Piot
Journal:  Genitourin Med       Date:  1993-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.